Philip Karl Herman - Net Worth and Insider Trading
Philip Karl Herman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Philip Karl Herman owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Philip Karl Herman’s form 4 insider trades.
Insider Ownership Summary of Philip Karl Herman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2020-01-01 | Sr. VP and CCO |
Philip Karl Herman Trading Performance
Philip Karl Herman Ownership Network
Philip Karl Herman Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Philip Karl Herman is the Sr. VP and CCO of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , Sr. VP and Head of Tech Op Torben Lund-hansen , and Sr. VP and COO Joris Wilms .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Philip Karl Herman made no insider transaction in Y-mAbs Therapeutics Inc (YMAB). Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net sale of 501,251 shares made by Thomas Gad , a net purchase of 380,768 shares made by Johan Wedell-wedellsborg , and a net purchase of 380,768 shares made by Biotech Aps Wg .
In summary, during the past 3 months, insiders sold 150,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 150,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 761,536 shares were bought by its insiders, resulting in a net purchase of 141,170 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Philip Karl Herman Mailing Address
Above is the net worth, insider trading, and ownership report for Philip Karl Herman. You might contact Philip Karl Herman via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, Suite 3350, New York Ny 10169.